Published by
The Street
The Street
By PR Newswire FAIRFIELD, N.J., Jan. 7, 2022 /PRNewswire/ — Vela Diagnostics announced that its Sentosa ® SQ HIV-1 Genotyping Assay is covered for reimbursement from The Centers for Medicare and Medicaid (CMS) starting January 2022. Based on the 2022 Clinical Diagnostic Laboratory Fee Schedule by CMS, healthcare providers using the Sentosa ® SQ HIV-1 Genotyping Assay solution with the assigned descriptor for therapeutic diagnoses can expect a reimbursement of US$725 using CPT code 0219U for HIV gene analysis*. The Sentosa ® SQ HIV-1 Genotyping Assay is a sample-to-result solution that uses Ne…